Stock Events

Stock Events

InnoCan Pharma 

0
89
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-4.29%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
23.21MRevenue
-996,926.62Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IP4.MU. It's not an investment recommendation.
Apple
3
AAPL
Amazon
3
AMZN
NVIDIA
3
NVDA
Alphabet
3
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap1.19B
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, competing in the same market as InnoCan.
Tilray Brands
TLRY
Mkt Cap533.49M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, making it a direct competitor to InnoCan Pharma.
Canopy Growth
CGC
Mkt Cap370.33M
Canopy Growth Corporation is a cannabis and cannabinoid-derived product company, competing in the same space as InnoCan Pharma.
Aurora Cannabis
ACB
Mkt Cap248.18M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, directly competing with InnoCan's offerings.
Direxion Daily CSI China Internet Index Bull 2X
CWEB
Mkt Cap0
Charlotte's Web Holdings, Inc. specializes in hemp-derived CBD products, competing in the cannabinoid-based product market alongside InnoCan Pharma.

About

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets. The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.
Show More
CEO
Iris Bincovich
Employees
11
Country
Canada
ISIN
CA45783P1027

Listings

MU
DE
IP4.MU
STU
DE
IP40.STU
F
DE
IP40.F
STU
DE
IP4.STU

0 Comments

Share your thoughts

FAQs

What is InnoCan Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange InnoCan Pharma stocks are traded under the ticker IP4.MU.
What is InnoCan Pharma revenue for the last year?▼
InnoCan Pharma revenue for the last year amounts to 23.21M EUR.
What is InnoCan Pharma net income for the last year?▼
IP4.MU net income for the last year is -996,926.62 EUR.
How many employees does InnoCan Pharma have?▼
As of November 2, 2026, the company has 11 employees.
In which sector is InnoCan Pharma located?▼
InnoCan Pharma operates in the Health & Wellness sector.
When did InnoCan Pharma complete a stock split?▼
The last stock split for InnoCan Pharma was on September 5, 2025 with a ratio of 1:65.
Where is InnoCan Pharma headquartered?▼
InnoCan Pharma is headquartered in Calgary, Canada.